The new cases of thelaziosis on the Balkan Peninsula

Main Article Content

Suzana Tasić-Otašević
Sara Savić
Stefan Momčilović
Marija Trenkić
Anastasia Diakou


Thelazia callipaeda (Spirurida, Thelaziidae), known as oriental eyeworm, is a parasite infesting the eyes of many domestic and wild carnivores which can also cause human infections. Due to the fact that infections by T. callipaeda have been recently spreading through the Balkan Peninsula, the main aims of this mini review are to give a clear and concise overview of the clinical manifestations, diagnosis and treatment of thelasiosis in animals and humans as well as to update epidemiological data about thelaziosis in this area. Clinical manifestations of thelaziosis can vary from subclinical to severe. In both animals and humans, treatment of thelaziosis can be effectively achieved with the removal of the nematodes from the eye under local anesthesia using a cotton swab or fine forceps. In the treatment of animals, antiparasitic drugs should be used supplementarily to the mechanical removal of parasites, while in humans, the topical use of antibiotics is desirable in order to prevent secondary bacterial infection. The growing number of diagnosed thelasiosis cases in dogs in the Balkan Peninsula, and particularly among owned pets in urban areas of Serbia previously considered free of infection, indicates the spread of zoonotic T. callipaeda in the area and in close proximity to humans. Finally, cooperation between veterinarians and physicians is strongly advocated in favour of the development of effective preventive measures and strategies.


Download data is not yet available.

Article Details

How to Cite
Tasić-Otašević, S., Savić, S., Momčilović, S., Trenkić, M., & Diakou, A. (2020). The new cases of thelaziosis on the Balkan Peninsula. Veterinarski Glasnik, 74(2), 154–163.
Mini Review


Bradbury R. S., Breen K. V., Bonura E. M., Hoyt J. W., Bishop H. S. 2019. Case Report: Conjunctival infestation with Thelazia gulosa: A novel agent of human thelaziasis in the United States. The American Journal of Tropical Medicine and Hygiene, 98:1171‐4.

Bianciardi P., Otranto D. 2005. Treatment of dog thelaziosis caused by Thelazia callipaeda (Spirurida, Thelaziidae) using a topical formulation of imidacloprid 10% and moxidectin 2.5%. Veterinary Parasitology, 129:89-93.

Chowdhury R., Gogoi M., Sarma A., Sharma A. 2018. Ocular thelaziasis: A case report from Assam, India. Tropical Parasitology, 8:94‐7.

Colella V., Kirkova Z., Fok É., Mihalca A.D., Tasić-Otašević S., Hodžić A., Dantas-Torres F., Otranto D. 2016. Increase in eyeworm infections in Eastern Europe. Emerging Infectious Diseases, 22:1513‐1515.

Diakou A. 2017. Thelazia callipaeda: vigilance is the best course of action. Veterinary Record, 181:344–5.

Diakou A., Di Cesare A., Tzimoulia S., Tzimoulias I., Traversa D. 2015. Thelazia callipaeda (Spirurida: Thelaziidae): first report in Greece and a case of canine infection. Parasitology Research, 114:2771–5.

do Vale B., Lopes A. P., da Conceição Fontes M., Silvestre M., Cardoso L., Coelho A. C. 2019. Thelaziosis due to Thelazia callipaeda in Europe in the 21st century – A review. Veterinary Parasitology, 275:108957.

Ferroglio E., Rossi L., Tomio E., Schenker R., Bianciardi P. 2008. Therapeutic and prophylactic efficacy of milbemycin oxime (Interceptor) against Thelazia callipaeda in naturally exposed dogs. Veterinary Parasitology, 154351-3.

Fuentes I, Montes I, Saugar J. M, Latrofa S, Gárate T, Otranto D. Thelaziosis in humans, a zoonotic infection, Spain, 2011. Emerg Infect Dis. 2012;18(12):2073

Gajić B., Bogunović D., Stevanović J., Kulišić Z., Simeunović P., Stanimirović Z. 2014. Canine and feline thelaziosis caused by Thelazia callipaeda in Serbia. Acta Veterinaria, 64:447-55.

Hodžić A., Latrofa M. S., Annoscia G., Alić A., Beck R., Lia R. P., Dantas-Torres F., Otranto D. 2014. The spread of zoonotic Thelazia callipaeda in the Balkan area. Parasites & Vectors, 7:352.

Ionică A. M., Deak G, D’Amico G., Stan G. F., Chișamera G. B., Constantinescu I. C., Adam C., Lefkaditis M., Gherman C. M., Mihalca A. D. 2019. Thelazia callipaeda in mustelids from Romania with the European badger, Meles meles, as a new host for this parasite. Parasites & Vectors, 12:370.

Jirku M., Kuchta R., Gricaj E., Modry D., Pomajbikova K. J. 2020. Canine thelaziosis in the Czech Republic: the northernmost autochthonous occurrence of the eye nematode Thelazia callipaeda Railliet et Henry, 1910 in Europe. Folia Parasitologica (Praha), 67:2020.010.

Koka K., Tongbram A., Mukherjee B., Muthusamy R., Nambi A., Biswas J. 2019. Periocular thelaziasis presenting as an orbital mass – a case report. Orbit, 38:503‐6.

Lebon W., Guillot J., Álvarez M. J., Antonio Bazaga J., Cortes-Dubly M. L., Dumont P., Eberhardt M., Gómez H., Pennant O., Siméon N., Beugnet F., Halos L. 2019. Prevention of canine ocular thelaziosis (Thelazia callipaeda) with a combination of milbemycin oxime and afoxolaner (Nexgard Spectra®) in endemic areas in France and Spain. Parasite, 26:1.

Lechat C., Siméon N., Pennant O., Desquilbet L., Chahory S., Le Sueur C., Guillot J. 2015. Comparative evaluation of the prophylactic activity of a slow-release insecticide collar and a moxidectin spot-on formulation against Thelazia callipaeda infection in naturally exposed dogs in France. Parasites and Vectors, 8:93.

Lia, R. P., Traversa D., Agostini A., Otranto D. 2004. Field efficacy of moxidectin 1 per cent against Thelazia callipaeda in naturally infected dogs. Veterinary Record, 154:143-5.

Maca J., Otranto D. 2014. Drosophilidae feeding on animals and the inherent mystery of their parasitism. Parasites & Vectors, 4:516.

Marino V., Gálvez R., Montoya A., Mascuñán C., Hernández M., Barrera J. P., Domínguez I., Zenker C., Checa R., Sarquis J., Miró G. 2020. Spain as a dispersion model for Thelazia callipaeda eyeworm in dogs in Europe. Preventive Veterinary Medicine, 175:104883.

Motta B., Nägeli F., Nägeli C., Solari-Basano F., Schiessl B., Deplazes P., Schnyder M. 2014. Epidemiology of the eye worm Thelazia callipaeda in cats from southern Switzerland. Veterinary Parasitology, 203:287-93.

Otranto D., Mendoza-Roldan J.A., Dantas-Torres F. 2020. Thelazia callipaeda. Trends in Parasitology, S1471-4922(20)30127-6.

Otranto D., Dutto M. Human thelaziasis, Europe. 2008. Emerging Infectious Diseases, 14:647-649.

Otranto D., Lia R. P., Cantacessi C., Testini G., Troccoli A., Shen J.L., Wang Z.X. 2005. Nematode biology and larval development of Thelazia callipaeda (Spirurida, Thelaziidae) in the drosophilid intermediate host in Europe and China. Parasitology, 131:847-55.

Otranto D., Cantacessi C., Testini G., Lia R. P. 2006. Phortica variegata as an intermediate host of Thelazia callipaeda under natural conditions: evidence for pathogen transmission by a male arthropod vector. International Journal for Parasitology, 36:1167-1173.

Otranto D., Lia R. P., Buono V., Traversa D., Giangaspero A. 2004. Biology of Thelazia callipaeda (Spirurida, Thelaziidae) eyeworms in naturally infected definitive hosts. Parasitology, 129:627-633.

Otranto D., Lia R. P., Traversa D., Giannetto S. 2003. Thelazia callipaeda (Spirurida, Thelaziidae) of carnivores and humans: morphological study by light and scanning electron microscopy. Parassitologia, 45:125-33.

Otranto D., Colella V., Crescenzo G., Solari Basano F., Nazzari R., Capelli G., Petry G., Schaper R., Pollmeier M., Mallia E., Dantas-Torres F., Lia R. P. 2016. Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs. Veterinary Parasitology, 227:118-21.

Otranto D., Solari Basano F., Pombi M., Capelli G., Nazzari R., Falsone .L, Petry G., Pollmeier M. G., Lia R. P. 2019. Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats. Parasites and Vectors, 12:25.

Otranto D., Deplazes P. 2019. Zoonotic nematodes of wild carnivores. International Journal for Parasitology: Parasites and Wildlife, 9:370–383.

Papadopoulos E., Komnenou A., Thomas A., Ioannidou E., Colella V., Otranto D. 2018. Spreading of Thelazia callipaeda in Greece. Transboundary and Emerging Diseases, 65: 248-52.

Pimenta P., Cardoso L., Pereira M.J., Maltez L., Coutinho T., Alves M.S., Otranto D. 2013. Canine ocular thelaziosis caused by Thelazia callipaeda in Portugal. Veterinary Ophthalmology, 16:312–5.

Rossi L., Rigano C., Tomio E., Frassetto D., Ferroglio E. 2007. Use of sustained-release moxidectin to prevent eyeworm (Thelazia callipaeda) infection in dogs. Veterinary Record 161:820-1.

Sharma M., Das D., Bhattacharjee H., Islam S., Deori N., Bharali G., Tomar S., Bhola P., Deka A. 2019. Human ocular thelaziasis caused by gravid Thelazia callipaeda - A unique and rare case report. Indian Journal of Ophthalmology, 67:282‐5.

Tasić-Otašević S., Gabrielli S., Trenkić-Božinović M., Petrović A., Gajić B., Colella V., Momčilović S., Cancrini G., Otranto D. 2016. Eyeworm infections in dogs and in a human patient in Serbia: A One Health approach is needed. Comparative Immunology, Microbiology and Infectious Diseases, 45:20-2.

Tomić-Paradžik M., Samardžic K., Živicnjak T., Martinkovic F., Janjetovic Ž., Miletić-Medved M. 2016. Thelazia callipaeda – first human case of thelaziosis in Croatia. Wiener Klinische Wochenschrift, 128: 221–3.

Most read articles by the same author(s)